You are here

Article Text

Article menu
Download PDFPDF
Editorial
Medical Editors Trial Amnesty (META)
  1. RICHARD SMITH
  1. Editor
  2. BMJ
  3. Child Health Monitoring Unit, Institute of Child Health, London WC1N 1EH
  4. Editor
  5. BJO
  1. IAN ROBERTS, Director
  1. Editor
  2. BMJ
  3. Child Health Monitoring Unit, Institute of Child Health, London WC1N 1EH
  4. Editor
  5. BJO
  1. JOHN V FORRESTER
  1. Editor
  2. BMJ
  3. Child Health Monitoring Unit, Institute of Child Health, London WC1N 1EH
  4. Editor
  5. BJO

    https://doi.org/10.1136/bjo.81.12.1028

    Statistics from Altmetric.com

      Request Permissions

      If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

      Currently over 100 medical journals around the world are inviting readers to send information on unpublished trials.150This amnesty should have important benefits for patients. Why?

      Reports of properly conducted randomised controlled trials are the foundation of effective health care, but many are not submitted for publication.12 This reduces the power of systematic reviews to detect moderate but clinically important treatment effects. Patients may thus be denied effective forms of health care. A second problem is that since trials that show more promising effects are more likely to be submitted, research syntheses …

      View Full Text

      Footnotes

      • ↵Since publication of this editorial in the BMJ in September there have been 25 submissions.